Global Acute Kidney Injury Drugs Market Growth 2026-2032
The global Acute Kidney Injury Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Acute Kidney Injury Drugs Industry Forecast? looks at past sales and reviews total world Acute Kidney Injury Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Acute Kidney Injury Drugs sales for 2026 through 2032. With Acute Kidney Injury Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Kidney Injury Drugs industry.
This Insight Report provides a comprehensive analysis of the global Acute Kidney Injury Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Kidney Injury Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acute Kidney Injury Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Kidney Injury Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Kidney Injury Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Kidney Injury Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Acute Kidney Injury Drugs Industry Forecast? looks at past sales and reviews total world Acute Kidney Injury Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Acute Kidney Injury Drugs sales for 2026 through 2032. With Acute Kidney Injury Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Kidney Injury Drugs industry.
This Insight Report provides a comprehensive analysis of the global Acute Kidney Injury Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Kidney Injury Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Acute Kidney Injury Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Kidney Injury Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Kidney Injury Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Kidney Injury Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Prerenal Acute Kidney Injury
- Postrenal Acute Kidney Injury
- Intrinsic Acute Kidney Injury
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Quark Pharmaceuticals
- Baxter International
- Fresenius Medical Care AG & Co. KGaA
- LG Chem
- Asahi Kasei Medical
- B. Braun Melsungen AG
- Angion Biomedica Corp
- What is the 10-year outlook for the global Acute Kidney Injury Drugs market?
- What factors are driving Acute Kidney Injury Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Acute Kidney Injury Drugs market opportunities vary by end market size?
- How does Acute Kidney Injury Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Kidney Injury Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Acute Kidney Injury Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Acute Kidney Injury Drugs by Country/Region, 2021, 2025 & 2032
2.2 Acute Kidney Injury Drugs Segment by Type
2.2.1 Prerenal Acute Kidney Injury
2.2.2 Postrenal Acute Kidney Injury
2.2.3 Intrinsic Acute Kidney Injury
2.2.4 Others
2.2.5 Acute Kidney Injury Drugs Sales by Type
2.2.5.1 Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Acute Kidney Injury Drugs Sale Price by Type (2021-2026)
2.3 Acute Kidney Injury Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Acute Kidney Injury Drugs Sales by Application
2.3.3.1 Global Acute Kidney Injury Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Acute Kidney Injury Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Acute Kidney Injury Drugs Breakdown Data by Company
3.1.1 Global Acute Kidney Injury Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Company (2021-2026)
3.2 Global Acute Kidney Injury Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Acute Kidney Injury Drugs Revenue by Company (2021-2026)
3.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Acute Kidney Injury Drugs Sale Price by Company
3.4 Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute Kidney Injury Drugs Product Location Distribution
3.4.2 Players Acute Kidney Injury Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Acute Kidney Injury Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Acute Kidney Injury Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Acute Kidney Injury Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Acute Kidney Injury Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Acute Kidney Injury Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Acute Kidney Injury Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acute Kidney Injury Drugs Sales Growth
4.4 APAC Acute Kidney Injury Drugs Sales Growth
4.5 Europe Acute Kidney Injury Drugs Sales Growth
4.6 Middle East & Africa Acute Kidney Injury Drugs Sales Growth
5 AMERICAS
5.1 Americas Acute Kidney Injury Drugs Sales by Country
5.1.1 Americas Acute Kidney Injury Drugs Sales by Country (2021-2026)
5.1.2 Americas Acute Kidney Injury Drugs Revenue by Country (2021-2026)
5.2 Americas Acute Kidney Injury Drugs Sales by Type (2021-2026)
5.3 Americas Acute Kidney Injury Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Kidney Injury Drugs Sales by Region
6.1.1 APAC Acute Kidney Injury Drugs Sales by Region (2021-2026)
6.1.2 APAC Acute Kidney Injury Drugs Revenue by Region (2021-2026)
6.2 APAC Acute Kidney Injury Drugs Sales by Type (2021-2026)
6.3 APAC Acute Kidney Injury Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acute Kidney Injury Drugs by Country
7.1.1 Europe Acute Kidney Injury Drugs Sales by Country (2021-2026)
7.1.2 Europe Acute Kidney Injury Drugs Revenue by Country (2021-2026)
7.2 Europe Acute Kidney Injury Drugs Sales by Type (2021-2026)
7.3 Europe Acute Kidney Injury Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Kidney Injury Drugs by Country
8.1.1 Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs
10.3 Manufacturing Process Analysis of Acute Kidney Injury Drugs
10.4 Industry Chain Structure of Acute Kidney Injury Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute Kidney Injury Drugs Distributors
11.3 Acute Kidney Injury Drugs Customer
12 WORLD FORECAST REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
12.1 Global Acute Kidney Injury Drugs Market Size Forecast by Region
12.1.1 Global Acute Kidney Injury Drugs Forecast by Region (2027-2032)
12.1.2 Global Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Acute Kidney Injury Drugs Forecast by Type (2027-2032)
12.7 Global Acute Kidney Injury Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Quark Pharmaceuticals
13.1.1 Quark Pharmaceuticals Company Information
13.1.2 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
13.1.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Quark Pharmaceuticals Main Business Overview
13.1.5 Quark Pharmaceuticals Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
13.2.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Fresenius Medical Care AG & Co. KGaA
13.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
13.3.2 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
13.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Medical Care AG & Co. KGaA Main Business Overview
13.3.5 Fresenius Medical Care AG & Co. KGaA Latest Developments
13.4 LG Chem
13.4.1 LG Chem Company Information
13.4.2 LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
13.4.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 LG Chem Main Business Overview
13.4.5 LG Chem Latest Developments
13.5 Asahi Kasei Medical
13.5.1 Asahi Kasei Medical Company Information
13.5.2 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
13.5.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Medical Main Business Overview
13.5.5 Asahi Kasei Medical Latest Developments
13.6 B. Braun Melsungen AG
13.6.1 B. Braun Melsungen AG Company Information
13.6.2 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
13.6.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 B. Braun Melsungen AG Main Business Overview
13.6.5 B. Braun Melsungen AG Latest Developments
13.7 Angion Biomedica Corp
13.7.1 Angion Biomedica Corp Company Information
13.7.2 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
13.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Angion Biomedica Corp Main Business Overview
13.7.5 Angion Biomedica Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Kidney Injury Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Acute Kidney Injury Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Acute Kidney Injury Drugs by Country/Region, 2021, 2025 & 2032
2.2 Acute Kidney Injury Drugs Segment by Type
2.2.1 Prerenal Acute Kidney Injury
2.2.2 Postrenal Acute Kidney Injury
2.2.3 Intrinsic Acute Kidney Injury
2.2.4 Others
2.2.5 Acute Kidney Injury Drugs Sales by Type
2.2.5.1 Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Acute Kidney Injury Drugs Sale Price by Type (2021-2026)
2.3 Acute Kidney Injury Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Acute Kidney Injury Drugs Sales by Application
2.3.3.1 Global Acute Kidney Injury Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Acute Kidney Injury Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Acute Kidney Injury Drugs Breakdown Data by Company
3.1.1 Global Acute Kidney Injury Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Company (2021-2026)
3.2 Global Acute Kidney Injury Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Acute Kidney Injury Drugs Revenue by Company (2021-2026)
3.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Acute Kidney Injury Drugs Sale Price by Company
3.4 Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute Kidney Injury Drugs Product Location Distribution
3.4.2 Players Acute Kidney Injury Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Acute Kidney Injury Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Acute Kidney Injury Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Acute Kidney Injury Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Acute Kidney Injury Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Acute Kidney Injury Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Acute Kidney Injury Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Acute Kidney Injury Drugs Sales Growth
4.4 APAC Acute Kidney Injury Drugs Sales Growth
4.5 Europe Acute Kidney Injury Drugs Sales Growth
4.6 Middle East & Africa Acute Kidney Injury Drugs Sales Growth
5 AMERICAS
5.1 Americas Acute Kidney Injury Drugs Sales by Country
5.1.1 Americas Acute Kidney Injury Drugs Sales by Country (2021-2026)
5.1.2 Americas Acute Kidney Injury Drugs Revenue by Country (2021-2026)
5.2 Americas Acute Kidney Injury Drugs Sales by Type (2021-2026)
5.3 Americas Acute Kidney Injury Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Kidney Injury Drugs Sales by Region
6.1.1 APAC Acute Kidney Injury Drugs Sales by Region (2021-2026)
6.1.2 APAC Acute Kidney Injury Drugs Revenue by Region (2021-2026)
6.2 APAC Acute Kidney Injury Drugs Sales by Type (2021-2026)
6.3 APAC Acute Kidney Injury Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acute Kidney Injury Drugs by Country
7.1.1 Europe Acute Kidney Injury Drugs Sales by Country (2021-2026)
7.1.2 Europe Acute Kidney Injury Drugs Revenue by Country (2021-2026)
7.2 Europe Acute Kidney Injury Drugs Sales by Type (2021-2026)
7.3 Europe Acute Kidney Injury Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Kidney Injury Drugs by Country
8.1.1 Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs
10.3 Manufacturing Process Analysis of Acute Kidney Injury Drugs
10.4 Industry Chain Structure of Acute Kidney Injury Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute Kidney Injury Drugs Distributors
11.3 Acute Kidney Injury Drugs Customer
12 WORLD FORECAST REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
12.1 Global Acute Kidney Injury Drugs Market Size Forecast by Region
12.1.1 Global Acute Kidney Injury Drugs Forecast by Region (2027-2032)
12.1.2 Global Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Acute Kidney Injury Drugs Forecast by Type (2027-2032)
12.7 Global Acute Kidney Injury Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Quark Pharmaceuticals
13.1.1 Quark Pharmaceuticals Company Information
13.1.2 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
13.1.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Quark Pharmaceuticals Main Business Overview
13.1.5 Quark Pharmaceuticals Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
13.2.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Fresenius Medical Care AG & Co. KGaA
13.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
13.3.2 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
13.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Medical Care AG & Co. KGaA Main Business Overview
13.3.5 Fresenius Medical Care AG & Co. KGaA Latest Developments
13.4 LG Chem
13.4.1 LG Chem Company Information
13.4.2 LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
13.4.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 LG Chem Main Business Overview
13.4.5 LG Chem Latest Developments
13.5 Asahi Kasei Medical
13.5.1 Asahi Kasei Medical Company Information
13.5.2 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
13.5.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Medical Main Business Overview
13.5.5 Asahi Kasei Medical Latest Developments
13.6 B. Braun Melsungen AG
13.6.1 B. Braun Melsungen AG Company Information
13.6.2 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
13.6.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 B. Braun Melsungen AG Main Business Overview
13.6.5 B. Braun Melsungen AG Latest Developments
13.7 Angion Biomedica Corp
13.7.1 Angion Biomedica Corp Company Information
13.7.2 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
13.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Angion Biomedica Corp Main Business Overview
13.7.5 Angion Biomedica Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acute Kidney Injury Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Acute Kidney Injury Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prerenal Acute Kidney Injury
Table 4. Major Players of Postrenal Acute Kidney Injury
Table 5. Major Players of Intrinsic Acute Kidney Injury
Table 6. Major Players of Others
Table 7. Global Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Acute Kidney Injury Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Acute Kidney Injury Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Acute Kidney Injury Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Acute Kidney Injury Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Acute Kidney Injury Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Acute Kidney Injury Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Acute Kidney Injury Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Acute Kidney Injury Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Acute Kidney Injury Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Acute Kidney Injury Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Acute Kidney Injury Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution and Sales Area
Table 23. Players Acute Kidney Injury Drugs Products Offered
Table 24. Acute Kidney Injury Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Acute Kidney Injury Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Acute Kidney Injury Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Acute Kidney Injury Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Acute Kidney Injury Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Acute Kidney Injury Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Acute Kidney Injury Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Acute Kidney Injury Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Acute Kidney Injury Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Acute Kidney Injury Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Acute Kidney Injury Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Acute Kidney Injury Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Acute Kidney Injury Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Acute Kidney Injury Drugs
Table 54. Key Market Challenges & Risks of Acute Kidney Injury Drugs
Table 55. Key Industry Trends of Acute Kidney Injury Drugs
Table 56. Acute Kidney Injury Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Acute Kidney Injury Drugs Distributors List
Table 59. Acute Kidney Injury Drugs Customer List
Table 60. Global Acute Kidney Injury Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Acute Kidney Injury Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Acute Kidney Injury Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Acute Kidney Injury Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Acute Kidney Injury Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Acute Kidney Injury Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Acute Kidney Injury Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Acute Kidney Injury Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Acute Kidney Injury Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Acute Kidney Injury Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Quark Pharmaceuticals Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 76. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Quark Pharmaceuticals Main Business
Table 78. Quark Pharmaceuticals Latest Developments
Table 79. Baxter International Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 81. Baxter International Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Baxter International Main Business
Table 83. Baxter International Latest Developments
Table 84. Fresenius Medical Care AG & Co. KGaA Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 86. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Fresenius Medical Care AG & Co. KGaA Main Business
Table 88. Fresenius Medical Care AG & Co. KGaA Latest Developments
Table 89. LG Chem Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 91. LG Chem Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. LG Chem Main Business
Table 93. LG Chem Latest Developments
Table 94. Asahi Kasei Medical Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 96. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Asahi Kasei Medical Main Business
Table 98. Asahi Kasei Medical Latest Developments
Table 99. B. Braun Melsungen AG Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 101. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. B. Braun Melsungen AG Main Business
Table 103. B. Braun Melsungen AG Latest Developments
Table 104. Angion Biomedica Corp Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 106. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Angion Biomedica Corp Main Business
Table 108. Angion Biomedica Corp Latest Developments
Table 1. Acute Kidney Injury Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Acute Kidney Injury Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prerenal Acute Kidney Injury
Table 4. Major Players of Postrenal Acute Kidney Injury
Table 5. Major Players of Intrinsic Acute Kidney Injury
Table 6. Major Players of Others
Table 7. Global Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Acute Kidney Injury Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Acute Kidney Injury Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Acute Kidney Injury Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Acute Kidney Injury Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Acute Kidney Injury Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Acute Kidney Injury Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Acute Kidney Injury Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Acute Kidney Injury Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Acute Kidney Injury Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Acute Kidney Injury Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Acute Kidney Injury Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution and Sales Area
Table 23. Players Acute Kidney Injury Drugs Products Offered
Table 24. Acute Kidney Injury Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Acute Kidney Injury Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Acute Kidney Injury Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Acute Kidney Injury Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Acute Kidney Injury Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Acute Kidney Injury Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Acute Kidney Injury Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Acute Kidney Injury Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Acute Kidney Injury Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Acute Kidney Injury Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Acute Kidney Injury Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Acute Kidney Injury Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Acute Kidney Injury Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Acute Kidney Injury Drugs
Table 54. Key Market Challenges & Risks of Acute Kidney Injury Drugs
Table 55. Key Industry Trends of Acute Kidney Injury Drugs
Table 56. Acute Kidney Injury Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Acute Kidney Injury Drugs Distributors List
Table 59. Acute Kidney Injury Drugs Customer List
Table 60. Global Acute Kidney Injury Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Acute Kidney Injury Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Acute Kidney Injury Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Acute Kidney Injury Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Acute Kidney Injury Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Acute Kidney Injury Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Acute Kidney Injury Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Acute Kidney Injury Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Acute Kidney Injury Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Acute Kidney Injury Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Quark Pharmaceuticals Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 76. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Quark Pharmaceuticals Main Business
Table 78. Quark Pharmaceuticals Latest Developments
Table 79. Baxter International Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 81. Baxter International Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Baxter International Main Business
Table 83. Baxter International Latest Developments
Table 84. Fresenius Medical Care AG & Co. KGaA Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 86. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Fresenius Medical Care AG & Co. KGaA Main Business
Table 88. Fresenius Medical Care AG & Co. KGaA Latest Developments
Table 89. LG Chem Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 91. LG Chem Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. LG Chem Main Business
Table 93. LG Chem Latest Developments
Table 94. Asahi Kasei Medical Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 96. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Asahi Kasei Medical Main Business
Table 98. Asahi Kasei Medical Latest Developments
Table 99. B. Braun Melsungen AG Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 101. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. B. Braun Melsungen AG Main Business
Table 103. B. Braun Melsungen AG Latest Developments
Table 104. Angion Biomedica Corp Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 106. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Angion Biomedica Corp Main Business
Table 108. Angion Biomedica Corp Latest Developments
LIST OF FIGURES
Figure 1. Picture of Acute Kidney Injury Drugs
Figure 2. Acute Kidney Injury Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Kidney Injury Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Acute Kidney Injury Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Acute Kidney Injury Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Acute Kidney Injury Drugs Sales Market Share by Country/Region (2025)
Figure 10. Acute Kidney Injury Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Prerenal Acute Kidney Injury
Figure 12. Product Picture of Postrenal Acute Kidney Injury
Figure 13. Product Picture of Intrinsic Acute Kidney Injury
Figure 14. Product Picture of Others
Figure 15. Global Acute Kidney Injury Drugs Sales Market Share by Type in 2026
Figure 16. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Acute Kidney Injury Drugs Consumed in Hospital
Figure 18. Global Acute Kidney Injury Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Acute Kidney Injury Drugs Consumed in Clinic
Figure 20. Global Acute Kidney Injury Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Global Acute Kidney Injury Drugs Sale Market Share by Application (2025)
Figure 22. Global Acute Kidney Injury Drugs Revenue Market Share by Application in 2026
Figure 23. Acute Kidney Injury Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Acute Kidney Injury Drugs Sales Market Share by Company in 2026
Figure 25. Acute Kidney Injury Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Acute Kidney Injury Drugs Revenue Market Share by Company in 2026
Figure 27. Global Acute Kidney Injury Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Acute Kidney Injury Drugs Sales Market Share by Country in 2026
Figure 38. Americas Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Acute Kidney Injury Drugs Sales Market Share by Region in 2026
Figure 46. APAC Acute Kidney Injury Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Acute Kidney Injury Drugs Sales Market Share by Country in 2026
Figure 57. Europe Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs in 2026
Figure 74. Manufacturing Process Analysis of Acute Kidney Injury Drugs
Figure 75. Industry Chain Structure of Acute Kidney Injury Drugs
Figure 76. Channels of Distribution
Figure 77. Global Acute Kidney Injury Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Acute Kidney Injury Drugs
Figure 2. Acute Kidney Injury Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Kidney Injury Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Acute Kidney Injury Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Acute Kidney Injury Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Acute Kidney Injury Drugs Sales Market Share by Country/Region (2025)
Figure 10. Acute Kidney Injury Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Prerenal Acute Kidney Injury
Figure 12. Product Picture of Postrenal Acute Kidney Injury
Figure 13. Product Picture of Intrinsic Acute Kidney Injury
Figure 14. Product Picture of Others
Figure 15. Global Acute Kidney Injury Drugs Sales Market Share by Type in 2026
Figure 16. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Acute Kidney Injury Drugs Consumed in Hospital
Figure 18. Global Acute Kidney Injury Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Acute Kidney Injury Drugs Consumed in Clinic
Figure 20. Global Acute Kidney Injury Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Global Acute Kidney Injury Drugs Sale Market Share by Application (2025)
Figure 22. Global Acute Kidney Injury Drugs Revenue Market Share by Application in 2026
Figure 23. Acute Kidney Injury Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Acute Kidney Injury Drugs Sales Market Share by Company in 2026
Figure 25. Acute Kidney Injury Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Acute Kidney Injury Drugs Revenue Market Share by Company in 2026
Figure 27. Global Acute Kidney Injury Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Acute Kidney Injury Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Acute Kidney Injury Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Acute Kidney Injury Drugs Sales Market Share by Country in 2026
Figure 38. Americas Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Acute Kidney Injury Drugs Sales Market Share by Region in 2026
Figure 46. APAC Acute Kidney Injury Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Acute Kidney Injury Drugs Sales Market Share by Country in 2026
Figure 57. Europe Acute Kidney Injury Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Acute Kidney Injury Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs in 2026
Figure 74. Manufacturing Process Analysis of Acute Kidney Injury Drugs
Figure 75. Industry Chain Structure of Acute Kidney Injury Drugs
Figure 76. Channels of Distribution
Figure 77. Global Acute Kidney Injury Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Application (2027-2032)
